More on KTOS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-750.0% Growth)
- Ratings (3.3 Score)
- Holders

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (11/7/16 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

KTOS Cash Flow Statement

Click line-items for a historical chart and %
Operating activities:
Net income (loss)
Less: Income from discontinued operations 100K
Income (loss) from continuing operations -32.5M
Adjustments to reconcile income (loss) from continuing operations to net cash provided by (used in) operating activities from continuing operations:
Depreciation and amortization 11.7M
Deferred income taxes 2M
Stock-based compensation 3.1M
Mark to market on swaps
Amortization of deferred financing costs 800K
Provision for doubtful accounts 200K
Changes in assets and liabilities, net of acquisitions:
Accounts receivable -6.2M
Inventoried costs -3.2M
Prepaid expenses and other assets 600K
Accounts payable -1.3M
Accrued compensation
Accrued expenses -2M
Billings in excess of costs and earnings on uncompleted contracts 900K
Income tax receivable and payable 100K
Other liabilities 400K
Net cash provided by (used in) operating activities from continuing operations -12.4M
Investing activities:
Cash paid for acquisitions, net of cash acquired
Increase in restricted cash 0
Other, net
Net cash used in investing activities from continuing operations -3.5M
Financing activities:
Proceeds from the issuance of long-term debt
Proceeds from the issuance of common stock
Borrowings under credit facility
Repayment under credit facility -500K
Debt issuance costs
Other
Net cash provided by financing activities from continuing operations 500K
Net cash flows of continuing operations -15.4M
Net operating cash flows of discontinued operations 100K
Net increase in cash and cash equivalents -10.9M
Cash and cash equivalents at beginning of period 28.5M
Cash and cash equivalents at end of period 17.6M